An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE).
This research is looking into a new medication, PIT565, for individuals living with Systemic Lupus Erythematosus (SLE). The main goals are to find out if PIT565 is safe to use, how well your body tolerates it, and how it moves through and leaves your system. Researchers also want to discover the right amount of medicine to give. This is a very early study (Phase 1), meaning it's one of the first times this medicine is being tested in people. The medicine will be given as an injection under the skin. As the study progresses, the dose may slowly increase to find the most effective and safest amount, while carefully checking for any side effects.
במבט חטוף
על מה המחקר הזה?
This study is about a new medicine called PIT565 for Systemic Lupus Erythematosus (SLE), or lupus. Lupus is a long-term condition that causes the body's immune system to mistakenly attack its own tissues and organs. Researchers are trying to find new ways to treat it.
In this study, the medicine PIT565 will be given as an injection just under the skin. This is an early-stage study, which means it's one of the first times PIT565 is being tried in people. The main aims are to see how safe it is, how your body reacts to it, and how much of it is needed to be effective. The dose of the medicine may be gradually increased for different groups of participants, but only if it's considered safe to do so.
The study will start with small groups of people, and if the medicine seems safe and shows some helpful effects, more people might join later at specific dose levels. This careful approach helps researchers understand the new medicine step-by-step, ensuring participant safety is always the top priority.
נקודות עיקריות
- This is an early study (Phase 1) looking at a new lupus medicine called PIT565.
- The main goals are to check the medicine's safety, how it's handled by the body, and the right dose.
- PIT565 is given as an injection under the skin.
- Participants must have active lupus that isn't responding well to current treatments.
- Careful monitoring and safety checks are a big part of the study.
מי עשוי להיות זכאי?
To join this study, you must be between 18 and 75 years old and have been diagnosed with lupus (SLE) using specific medical guidelines. Your lupus should also be active, meaning you are currently experiencing symptoms, and your current lupus treatments should not be working well enough.
You would not be able to join if you have very severe lupus that has caused significant organ damage or is life-threatening, or if you are having a serious flare-up that needs immediate treatment. Also, if you have severe kidney problems related to lupus that require strong medication, you might not be suitable. Other conditions like serious heart problems, certain severe infections (like HIV or hepatitis), or other serious medical illnesses could also prevent you from taking part.
Women who could become pregnant would need to be using very reliable birth control methods to be considered for the study.
האם מחקר זה יכול להתאים לך?
ענה על השאלות המהירות הללו כדי לבדוק אם אתה עשוי להיות זכאי. זהו מדריך בלבד — צוות המחקר מקבל את ההחלטה הסופית.
- האם אתה בין גיל 18 ל-75?
- Do you have a confirmed diagnosis of lupus (SLE)?
- Is your lupus currently active, despite your usual treatments?
- Have you been vaccinated against common infections like flu and COVID-19?
- Do you have any severe organ damage or life-threatening lupus flares?
- If you are a woman, are you able to use effective birth control?
מה כרוך בהשתתפות?
If you decide to take part, you would receive the study medicine, PIT565, as an injection under your skin. Before each dose, you might receive other medicines to help prevent any reactions. The study involves different groups of people, and the dose of PIT565 might be different for each group, starting low and possibly increasing if it's safe.
The researchers will closely monitor your health and any effects of the medicine. This will involve regular visits to the clinic for check-ups, blood tests, and other assessments. The total time you would be involved in the study is not specified, but early-stage studies like this often involve several weeks or months of close monitoring.
סיכונים ותועלות פוטנציאליים
מיקומים (13)
- אתר חקירות נוברטיסמיקוד מאומתSofia, Bulgaria· נמשך
- אתר חקירות נוברטיסמיקוד מאומתבייג'ינג, סין· גיוס
- אתר חקירות נוברטיסמיקוד מאומתבייג'ינג, סין· גיוס
- אתר חקירות נוברטיסמיקוד מאומתברלין, גרמניה· גיוס
- אתר חקירות נוברטיסמיקוד מאומתמיינץ, גרמניה· גיוס
- אתר חקירות נוברטיסמיקוד מאומתבודפשט, הונגריה· גיוס
- אתר חקירות נוברטיסמיקוד מאומתSzeged, Hungary· גיוס
- אתר חקירות נוברטיסמיקוד מאומתליידן, הולנד· גיוס
- אתר חקירות נוברטיסעיר בלבדSantiago Compostela, Spain· גיוס
- אתר חקירות נוברטיסמיקוד מאומתברצלונה, ספרד· גיוס
- אתר חקירות נוברטיסמיקוד מאומתמדריד, ספרד· גיוס
- אתר חקירות נוברטיסמיקוד מאומתBern, Switzerland· גיוס
שאלות נפוצות
What is PIT565?
PIT565 is a new medicine being tested for people with lupus (SLE). It's in the early stages of development.
מדוע מחקר זה חשוב?
This study helps researchers understand if PIT565 is safe and how it works in the body, which could lead to a new treatment option for lupus.
האם אדע אם אני מקבל את התרופה האמיתית?
Yes, everyone in this study will receive PIT565. There isn't a placebo (dummy medicine) group.
כיצד יינתן התרופה?
The medicine PIT565 will be given as an injection just under the skin.
מה אם אני מרגיש לא טוב במהלך המחקר?
Your health will be closely monitored, and you can withdraw from the study at any time if you feel unwell or for any other reason.
כיצד לגלות עוד
נוברטיס פרמצבטיקה
תמיד התייעץ עם רופא המשפחה או המומחה שלך לפני שתחליט להשתתף במחקר.
מעוניינים להשתתף?
דיון
דיון קהילתי
מופעל על ידי הפורום שלנו ב community.patient.info. אנא היו מכבדים — זה אינו ייעוץ רפואי.